美国弹性胶带市场规模、份额和趋势分析报告：按适应症、弹性等级和细分市场预测，2025-2033年

美国弹性胶带市场概况

2024年美国压缩胶带市场规模估计为3,365万美元，预计2033年将达到4,618万美元。

预计从 2025 年到 2033 年，该市场将以 3.61% 的复合年增长率成长。随着医疗保健机构越来越多地使用加压解决方案进行伤口管理、术后护理和肿胀控制，该市场正在扩张。

运动和健身参与度的提高推动了用于预防和復健的弹性贴扎产品的需求成长。医院、门诊中心和居家医疗机构越来越多地采用弹性贴扎产品来帮助患者早期活动并减少併发症。零售和电商通路的拓展也进一步推动了各用户群的购买量成长。

美国弹性绷带产业持续成长，这主要得益于局部加压治疗中黏合型和环绕型产品的使用日益增多。静脉和淋巴疾病发生率的上升，包括慢性静脉功能不全、深层静脉栓塞症、血栓后症候群和淋巴水肿，也推动了市场需求。此外，手术量的增加、肥胖症的流行以及久坐不动的生活方式也促进了弹性绷带的使用。目前，弹性绷带已被广泛应用于医院、门诊和居家照护等场所，用于控制肿胀、稳定肢体以及术后支撑。

运动参与度和运动伤害发生率是推动需求成长的其他因素。弹性胶带可直接贴于皮肤或绷带之上，用于支撑肌肉、肌腱和关节，缓解肿胀，并改善运动和恢復期间的血液循环。儿童和青少年在有组织的运动中受伤率居高不下，推动了运动和物理治疗领域对弹性胶带的需求成长。弹性胶带提供灵活的支撑，且不限制运动，因此适用于復健治疗和重复使用。

它们在术后护理中的作用也推动了市场扩张。在医院和门诊手术中心，牵引疗法已成为控制肿胀和减少併发症的标准通讯协定。居家照护和销售管道的成长正在推动低成本、易于使用且适用于各种肢体形态的胶带产品的普及。主要趋势包括客製化包扎方案、改进的纤维系统以支援患者使用，以及专为长时间佩戴而设计的黏合剂。製造商正透过推出混合胶带绷带产品、多日黏合剂产品以及儘早整合监测功能来应对这些需求。

慢性静脉疾病（包括慢性静脉功能不全 (CVI)、静脉曲张、深层静脉栓塞症(DVT) 和静脉性腿部溃疡）的日益增多，是推动弹性疗法市场发展的主要因素。久坐的生活方式、肥胖、人口老化以及长时间站立和职场等因素，显着加剧了这些疾病在全球的负担。

根据美国血管外科协会2025年7月发布的数据，慢性静脉功能不全影响高达40%的美国。同样，根据WebMD LLC 2025年7月发布的数据，美国40至80岁的人群中，超过1100万男性和2200万女性患有静脉曲张，其中超过200万人患有晚期慢性静脉功能不全。每年，超过2万人被诊断出患有慢性静脉功能不全引起的溃疡。

目录

第一章调查方法和范围

第二章执行摘要

第三章美国弹性胶带市场变数、趋势与范围

• 市场谱系展望
  • 母市场展望
  • 相关及附随市场展望
• 市场动态
• 美国弹性胶带市场分析工具
  • 产业分析：波特五力模型
  • PESTEL 分析
  • 法律规范
  • 救赎方案

第四章美国弹性胶带市场：按应用分類的估算与趋势分析

• 按适应症分類的市场份额（2024 年和 2033 年）
• 美国弹性胶带市场按适应症展望
• 市场规模、预测与趋势分析（2021-2033）
  • 运动伤害
  • 术后水肿
  • 淋巴水肿

第五章美国弹性胶带市场：依弹性等级分類的估算与趋势分析

• 以伸缩臂望远镜类别分類的市场份额（2024 年和 2033 年）
• 美国弹性胶带市场：按弹性等级分類的展望
• 市场规模、预测与趋势分析（2021-2033）
  • 一年级
  • 二年级

第六章 竞争情势

• 主要市场参与企业的最新趋势和影响分析
• 公司/竞争对手分类
• 供应商概况
  • 主要经销商和通路合作伙伴名单
  • Key customers
  • Key company market share analysis, 2024
• 公司简介
  • Essity Aktiebolag
  • Hartmann AG
  • Medline Industries, LP.
  • 3M
  • Mueller Sports Medicine
  • Dynarex
  • DeRoyal
  • Andover Healthcare
  • Cardinal Health

U.S. Compression Tape Market Summary

The U.S. compression tape market size was estimated at USD 33.65 million in 2024 and is projected to reach USD 46.18 million by 2033, growing at a CAGR of 3.61% from 2025 to 2033. The market is expanding as healthcare providers increase the use of compression solutions for injury management, post-operative care, and swelling control.

Growing participation in sports and fitness is driving higher demand for preventive and recovery-focused taping. Hospitals, outpatient centers, and home-care settings are adopting compression products to support faster mobilization and reduce secondary complications. Broader access through retail and e-commerce channels is further supporting volume growth across user groups.

The U.S. compression tape industry continues to expand, driven by growing use of adhesive and wrap-style products for localized compression. Demand is supported by rising incidence of venous and lymphatic conditions such as chronic venous insufficiency, deep-vein thrombosis, post-thrombotic syndromes, and lymphedema. Increasing surgical volumes, obesity, and inactive lifestyles further contribute to utilization, with compression tapes used across hospital, outpatient, and home-care settings for swelling management, stabilization, and post-procedure support.

Sports participation and injury incidence form another driver of demand. Compression tapes are applied directly on skin or over dressings to support muscles, tendons, joints, manage swelling, and assist circulation during activity or recovery. The high volume of injuries among children and adolescents in organized sports increases consumption in athletic and physiotherapy channels. Tapes provide flexible support without restricting full movement, making them suitable for rehabilitation and repeated-use scenarios.

The market also benefits from their role in post-operative care. Protocols in hospitals and ambulatory surgery centers integrate compression for swelling management and complication reduction. Growth in home-care and direct-to-consumer channels supports wider use of tape formats that are low-cost, easy to apply, and adaptable to varied limb shapes. Trends include custom-fit wrap options, improved textile systems to support patient use, and adhesive formats designed for extended wear. Manufacturers respond with tape-wrap hybrids, multi-day adhesive products, and early integration of monitoring features.

The increasing prevalence of chronic venous disorders, including chronic venous insufficiency (CVI), varicose veins, deep vein thrombosis (DVT), and venous leg ulcers-is a key driver of the compression therapy market. Factors such as sedentary lifestyles, obesity, aging populations, and prolonged periods of standing or sitting at work are significantly contributing to the growing global burden of these conditions.

According to data published by the Society for Vascular Surgery in July 2025, chronic venous insufficiency affects up to 40% of Americans. Similarly, data from WebMD LLC published in July 2025 indicate that in the U.S., more than 11 million men and 22 million women aged 40-80 years suffer from varicose veins, while over 2 million individuals are affected by advanced CVI. Each year, more than 20,000 people are diagnosed with ulcers resulting from CVI.

U.S. Compression Tape Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. compression tape market report based on indication, and compression class:

• Indication Outlook (Revenue, USD Million, 2021 - 2033)
• Sports Injuries
• Post-operative Edema
• Lymphedema
• Compression Class Outlook (Revenue, USD Million, 2021 - 2033)
• Class 1
• Class 2

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Indication
  • 1.2.2. Compression class
  • 1.2.3. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Volume price analysis (Model 2)
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Indication Outlook
  • 2.2.2. Compression class outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Compression Tape Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Rising incidence of venous and lymphatic conditions
    • 3.2.1.2. Expansion of sports activity and injury rates
    • 3.2.1.3. Innovation in elastic/cohesive wrap technology
  • 3.2.2. Market Restraint Impact Analysis
    • 3.2.2.1. Alternative Treatment Options
    • 3.2.2.2. Adverse Effects Associated with Compression Therapy
  • 3.2.3. Market Opportunity Impact Analysis
    • 3.2.3.1. Product innovation in materials and hybrid formats
    • 3.2.3.2. Increasing Number of Clinical Trials
  • 3.2.4. Market Challenge Impact Analysis
    • 3.2.4.1. Product Recalls
• 3.3. U.S. Compression Tape Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape
  • 3.3.3. Regulatory Framework
  • 3.3.4. Reimbursement Scenario

Chapter 4. U.S. Compression Tape Market: Indication Estimates & Trend Analysis

• 4.1. Indication Market Share, 2024 & 2033
• 4.2. Segment Dashboard
• 4.3. U.S. Compression Tape Market by Indication Outlook
• 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 4.4.1. Sports Injuries
    • 4.4.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.4.2. Post-operative Edema
    • 4.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.4.3. Lymphedema
    • 4.4.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. U.S. Compression Tape Market: Compression Class Estimates & Trend Analysis

• 5.1. Compression Class Market Share, 2024 & 2033
• 5.2. Segment Dashboard
• 5.3. U.S. Compression Tape Market by Compression Class Outlook
• 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 5.4.1. Class 1
    • 5.4.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.4.2. Class 2
    • 5.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Competitive Landscape

• 6.1. Recent Developments & Impact Analysis By Key Market Participants
• 6.2. Company/Competition Categorization
• 6.3. Vendor Landscape
  • 6.3.1. List of key distributors and channel partners
  • 6.3.2. Key customers
  • 6.3.3. Key company market share analysis, 2024
• 6.4. Company Profiles
  • 6.4.1. Essity Aktiebolag
    • 6.4.1.1. Company overview
    • 6.4.1.2. Financial performance
    • 6.4.1.3. Product benchmarking
    • 6.4.1.4. Strategic initiatives
  • 6.4.2. Hartmann AG
    • 6.4.2.1. Company overview
    • 6.4.2.2. Financial performance
    • 6.4.2.3. Product benchmarking
    • 6.4.2.4. Strategic initiatives
  • 6.4.3. Medline Industries, LP.
    • 6.4.3.1. Company overview
    • 6.4.3.2. Financial performance
    • 6.4.3.3. Product benchmarking
    • 6.4.3.4. Strategic initiatives
  • 6.4.4. 3M
    • 6.4.4.1. Company overview
    • 6.4.4.2. Financial performance
    • 6.4.4.3. Product benchmarking
    • 6.4.4.4. Strategic initiatives
  • 6.4.5. Mueller Sports Medicine
    • 6.4.5.1. Company overview
    • 6.4.5.2. Financial performance
    • 6.4.5.3. Product benchmarking
    • 6.4.5.4. Strategic initiatives
  • 6.4.6. Dynarex
    • 6.4.6.1. Company overview
    • 6.4.6.2. Financial performance
    • 6.4.6.3. Product benchmarking
    • 6.4.6.4. Strategic initiatives
  • 6.4.7. DeRoyal
    • 6.4.7.1. Company overview
    • 6.4.7.2. Financial performance
    • 6.4.7.3. Product benchmarking
    • 6.4.7.4. Strategic initiatives
  • 6.4.8. Andover Healthcare
    • 6.4.8.1. Company overview
    • 6.4.8.2. Financial performance
    • 6.4.8.3. Product benchmarking
    • 6.4.8.4. Strategic initiatives
  • 6.4.9. Cardinal Health
    • 6.4.9.1. Company overview
    • 6.4.9.2. Financial performance
    • 6.4.9.3. Product benchmarking
    • 6.4.9.4. Strategic initiatives

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviations
• Table 3 U.S. compression tape market revenue estimates and forecast, by indication, 2021 - 2033 (Million)
• Table 4 U.S. compression tape market revenue estimates and forecast, by compression class, 2021 - 2033 (Million)
• Table 5 Key companies undergoing new product launches and regulatory approvals
• Table 6 Key companies undergoing collaborations/partnerships/agreements
• Table 7 Key companies undergoing expansions
• Table 8 Key companies undergoing acquisition

List of Figures

• Fig. 1 U.S. compression tape market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value chain-based sizing & forecasting
• Fig. 7 Market formulation & validation
• Fig. 8 Market snapshot
• Fig. 9 Segment snapshot (indication & compression class)
• Fig. 10 Competitive landscape
• Fig. 11 U.S. compression tape market: PORTER's analysis
• Fig. 12 U.S. compression tape market: PESTEL analysis
• Fig. 13 U.S. compression tape market, by indication: Key takeaways
• Fig. 14 U.S. compression tape market, by indication: Market share, 2024 & 2033
• Fig. 15 Sports Injuries market, 2021 - 2033 (USD Million)
• Fig. 16 Post-operative Edema market, 2021 - 2033 (USD Million)
• Fig. 17 Lymphedema market, 2021 - 2033 (USD Million)
• Fig. 18 U.S. compression tape market, by compression class: Key takeaways
• Fig. 19 U.S. compression tape market, by compression class: Market share, 2024 & 2033
• Fig. 20 Class 1 market, 2021 - 2033 (USD Million)
• Fig. 21 Class 2 market, 2021 - 2033 (USD Million)
• Fig. 22 Key company categorization
• Fig. 23 Company share analysis, 2024 (%)
• Fig. 24 Strategy mapping